Biodesix, Inc. (BDSX) Reports Q1 Loss, Misses Revenue Estimates

Biodesix, Inc. (BDSX) came out with a quarterly loss of $0.08 per share in line with the Zacks Consensus Estimate. This compares to loss of$0.14 per share a year ago. These figures are adjusted for non-recurring items.A quarter ago, it was expected that this company would post a loss of $0.07 per share when it actually produced a loss of$0.06, delivering a surprise of 14.29%.Over the last four quarters, the company has surpassed consensus EPS estimates three times.Biodesix, which belongs to the Zacks Medi ...